Security key
45824Q804
Glucotrack, Inc. - Common Stock, par value $0.001 per share (GCTK)
CUSIP: 45824Q804
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 2,046,393
- Total 13F shares
- 6,298
- Share change
- -383
- Total reported value
- $41,504
- Price per share
- $6.59
- Number of holders
- 8
- Value change
- -$1,996
- Number of buys
- 3
- Number of sells
- 6
Report period
Q3 2025
Institutions
8
Top holders
8
GCTK full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Glucotrack, Inc. SEC filings
Glucotrack, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45824Q804
Recent filing periods:
Top shareholders of GCTK - Glucotrack, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC |
13D/G
|
— |
4.9%
|
647,055
|
$241,352 | $0 | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.2%
|
4,089
|
$24,534 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.09%
|
1,772
|
$10,632 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.04%
|
751
|
$4,506 | — | 30 Jun 2025 | |
| NFSG Corp |
13F
|
Company |
0%
|
34
|
$204 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
0%
|
21
|
$128 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
10
|
$60 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1
|
$6 | — | 30 Jun 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
1
|
$6 | — | 30 Jun 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
1
|
$6 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
1
|
$6 | — | 30 Jun 2025 | |
| John Ballantyne |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
2,939,013
mixed-class rows
|
$85,179,227 | — | 16 Aug 2024 | |
| John A. Ballantyne Revocable Living Trust dated 08/01/2017 |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
2,934,887
mixed-class rows
|
$85,051,321 | — | 30 Jul 2024 | |
| Drew Sycoff |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
3,089,258
mixed-class rows
|
$3,718,585 | — | 01 Jul 2024 | |
| Robert Fischell |
3/4/5
|
Director |
—
class O/S missing
|
2,045
|
$63,804 | — | 24 Aug 2021 | |
| Andrew K. Balo |
3/4/5
|
Director |
—
mixed-class rows
|
8,747
mixed-class rows
|
$22,850 | — | 26 Mar 2025 | |
| Luis Malave |
3/4/5
|
Director |
—
mixed-class rows
|
14,999
mixed-class rows
|
$19,762 | — | 25 Mar 2025 | |
| Allen Danzig |
3/4/5
|
Director |
—
class O/S missing
|
1,922
|
$18,960 | — | 04 Oct 2022 | |
| Erin Catherine Carter |
3/4/5
|
Director |
—
mixed-class rows
|
8,281
mixed-class rows
|
$10,460 | — | 25 Mar 2025 | |
| Paul Goode |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
6,512
mixed-class rows
|
$1,650 | — | 25 Mar 2025 |
Institutional Holders of Glucotrack, Inc. - Common Stock, par value $0.001 per share (GCTK) as of Q3 2025
As of 30 Sep 2025,
Glucotrack, Inc. - Common Stock, par value $0.001 per share (GCTK) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,298 shares.
The largest 8 holders included
ALERUS FINANCIAL NA, Tower Research Capital LLC (TRC), MORGAN STANLEY, UBS Group AG, Newbridge Financial Services Group, Inc., SBI Securities Co., Ltd., BANK OF AMERICA CORP /DE/, and OSAIC HOLDINGS, INC..
This page lists
8
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
10
Q3 2025 holders
8
Holder diff
-2
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.